SIK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.709800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.171600E-01
Normal-vs-Stage2
6.999200E-01
Normal-vs-Stage3
5.432800E-01
Normal-vs-Stage4
5.207200E-01
Stage1-vs-Stage2
7.115400E-01
Stage1-vs-Stage3
4.144400E-01
Stage1-vs-Stage4
2.653000E-01
Stage2-vs-Stage3
6.182000E-01
Stage2-vs-Stage4
1.115960E-01
Stage3-vs-Stage4
1.144410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.824200E-01
Normal-vs-AfricanAmerican
8.199000E-01
Normal-vs-Asian
4.103600E-01
Caucasian-vs-AfricanAmerican
5.219600E-01
Caucasian-vs-Asian
1.840430E-01
AfricanAmerican-vs-Asian
1.795570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.983200E-01
Normal-vs-Female
9.729800E-01
Male-vs-Female
3.816200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.068600E-01
Normal-vs-Age(41-60Yrs)
8.048400E-01
Normal-vs-Age(61-80Yrs)
7.989200E-01
Normal-vs-Age(81-100Yrs)
2.215600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.838400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.976400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.994170E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.384300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.676080E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.189800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.381200E-01
Normal-vs-Daily Drinker
2.963600E-01
Normal-vs-Weekly Drinker
5.593600E-01
Normal-vs-Occasional Drinker
8.581600E-01
Normal-vs-Social Drinker
8.639600E-01
Non Drinker-vs-Daily Drinker
4.133600E-01
Non Drinker-vs-Weekly Drinker
8.828000E-01
Non Drinker-vs-Occasional Drinker
2.346600E-01
Non Drinker-vs-Social Drinker
2.231200E-01
Daily Drinker-vs-Weekly Drinker
6.094600E-01
Daily Drinker-vs-Occasional Drinker
1.097380E-01
Daily Drinker-vs-Social Drinker
9.558200E-02
Weekly Drinker-vs-Occasional Drinker
2.409200E-01
Weekly Drinker-vs-Social Drinker
2.392400E-01
Occasional Drinker-vs-Social Drinker
9.449800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.676210E-01
Normal-vs-Grade 2
1.631810E-02
Normal-vs-Grade 3
8.243200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.326600E-01
Grade 1-vs-Grade 3
3.227000E-01
Grade 1-vs-Grade 4
1.676210E-01
Grade 2-vs-Grade 3
9.315600E-01
Grade 2-vs-Grade 4
1.631810E-02
Grade 3-vs-Grade 4
8.243200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.996800E-01
Normal-vs-NonDiabetic
7.896600E-01
Diabetic-vs-NonDiabetic
9.631000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.463200E-01
Normal-vs-NoPancreatitis
8.230600E-01
Pancreatitis-vs-NoPancreatitis
5.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.844800E-01
Normal-vs-N1
7.637200E-01
N0-vs-N1
4.353400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.879200E-01
Normal-vs-TP53-NonMutant
7.894000E-01
TP53-Mutant-vs-TP53-NonMutant
8.507600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
